CN1284555C - Compound fineleaf schizonepeta oil soft capsule - Google Patents
Compound fineleaf schizonepeta oil soft capsule Download PDFInfo
- Publication number
- CN1284555C CN1284555C CN 200410050545 CN200410050545A CN1284555C CN 1284555 C CN1284555 C CN 1284555C CN 200410050545 CN200410050545 CN 200410050545 CN 200410050545 A CN200410050545 A CN 200410050545A CN 1284555 C CN1284555 C CN 1284555C
- Authority
- CN
- China
- Prior art keywords
- oil
- grams
- nepeta
- compound
- forsythia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a compound nepeta oil soft capsule for solving the problems that the existing nepeta oil medicaments can not be conveniently taken, and the lose of the effective components of nepeta oil because of volatilization in the process of preparation and storage causing the treating effects of single nepeta oil medicaments to be unnoticeable. Measured by 1000 granules, the compound nepeta oil soft capsule is prepared from 50 to 500g of nepeta oil, 50 to 300g of forsythia, 50 to 500g of plant volatile oil, 0 to 850g of soybean oil and capsule materials. The compound nepeta oil soft capsule has the advantages that the nepeta oil matched with forsythia oil and the plant volatile oil enhances the effects on fever removal, bacterium resistance, virus resistance, inflammation resistance, nasal cavity dredging, and the like and also has a good fever relieving effect on biologic fever; the compound medicament prepared from the nepeta oil and the forsythia oil has a synergistic effect, enlarges an antibacterial spectrum, has an obvious fever and inflammation relieving effect, more obvious treating effects than the single use of the nepeta oil or the single use of forsythia oil and small toxic or side effect, ensures the stability of the medicament and has the advantages of high bioavailability, safe use, obvious and fast treating effect, convenient oral administration and portability.
Description
Technical field
The invention belongs to a kind of Chinese medicine preparation, particularly a kind of compound schizonepeta fat capsule.
Background technology
Herba Schizonepetae is just on the books in Compendium of Material Medica as diaphoretic medicine, and the clinical use Herba Schizonepetae of modern medicine mainly concentrates on expelling pathogenic wind from the body surface, and refresh oneself, throat, rash, the skin ulcer that disappears are antipruritic, aspects such as hemostasis, clearing the nasal passage, expelling wind to relieve convulsion.The effective constituent that mainly contains of Herba Schizonepetae is a Herba Schizonepetae volatile oil, and traditional method is with mode administrations such as decoction, pill, powder, tablet and hard capsule, the inconvenience of taking medicine; Herba Schizonepetae oil because of volatilization makes the very big or loss fully of effective component content loss, is not brought into play its curative effect fully in preparation and storage process; In addition, single Herba Schizonepetae oil preparation curative effect is not remarkable.
Summary of the invention
The present invention will provide a kind of drug effect of Herba Schizonepetae oil and stability not volatile, that can guarantee this medicine given full play to, bioavailability height, the compound schizonepeta fat capsule of evident in efficacy, taking convenience.
This compound schizonepeta fat capsule is made up of Herba Schizonepetae oil 50～500 grams, Fructus Forsythiae oil 50～300 grams, plant volatile oil 50～500 grams, soybean oil 0～850 gram and capsule material in 1000.
Advantage of the present invention is that Herba Schizonepetae oil cooperates Fructus Forsythiae oil and plant volatile oil, more strengthened the analgesic of Herba Schizonepetae oil, antibiotic, antiviral, antiinflammatory, effects such as clearing the nasal passage and biological heating also had well separate thermal effect, Herba Schizonepetae oil and Fructus Forsythiae oil are formed compound preparation and are had synergism, enlarge antimicrobial spectrum and had tangible antipyretic and anti-inflammatory effect, more obvious than single with Herba Schizonepetae oil or single Fructus Forsythiae oil curative effect of using, and toxic and side effects is little, after making soft capsule, make volatile Herba Schizonepetae oil, the stability of Fructus Forsythiae oil and plant volatile oil strengthens greatly, guaranteed the stable of this medicine, and the bioavailability height; Safe in utilization, evident in efficacy, curative effect is fast, is convenient to oral, easy to carry.
The specific embodiment
Embodiment 1:
Get Herba Schizonepetae oil 50 grams, Fructus Forsythiae oil 50 grams, plant volatile oil 50 grams, soybean oil 150 grams or 350 grams or 850 grams, mixed and stir, cross 100 mesh sieves, make medicinal liquid, by weight got gelatin in 1: 0.3～0.4: 1.2, G ﹠ W is made the capsule material, and above-mentioned medicinal liquid and capsule material 100 grams or 300 grams or 200 grams are pressed into 1000 of soft capsules on encapsulating machine.
Embodiment 2:
Get Herba Schizonepetae oil 500 grams, Fructus Forsythiae oil 300 grams, plant volatile oil 200 grams or Herba Schizonepetae oil 200 grams, Fructus Forsythiae oil 300 grams, plant volatile oil 500 grams or Herba Schizonepetae oil 400 grams, Fructus Forsythiae oil 200 grams, plant volatile oil 400 grams, or Herba Schizonepetae oil 50 grams, Fructus Forsythiae oil 50 grams, plant volatile oil 200 grams or Herba Schizonepetae oil 200 grams, Fructus Forsythiae oil 50 grams, plant volatile oil 50 grams or Herba Schizonepetae oil 120 grams, Fructus Forsythiae oil 60 grams, plant volatile oil 120 grams, or Herba Schizonepetae oil 200 grams, Fructus Forsythiae oil 100 grams, plant volatile oil 200, mixed and stir, cross 100 mesh sieves, make medicinal liquid, got gelatin by weight 1: 0.3～0.4: 1.2, G ﹠ W is made the capsule material, and above-mentioned medicinal liquid and capsule material 100 grams or 200 grams or 300 grams are pressed into 1000 of soft capsules on encapsulating machine.
Embodiment 3:
Get Herba Schizonepetae oil 400 grams, Fructus Forsythiae oil 100 grams, plant volatile oil 450 grams and soybean oil 50 grams or Herba Schizonepetae oil 100 grams, Fructus Forsythiae oil 60 grams, plant volatile oil 90 grams and soybean oil 50 grams or Herba Schizonepetae oil 190 grams, Fructus Forsythiae oil 80 grams, plant volatile oil 180 grams and soybean oil 50 grams, mixed and stir, cross 100 mesh sieves, make medicinal liquid, by weight got gelatin in 1: 0.3～0.4: 1.2, G ﹠ W is made the capsule material, and above-mentioned medicinal liquid and capsule material 100 grams or 200 grams or 300 grams are pressed into 1000 of soft capsules on encapsulating machine.
Embodiment 4:
Get Herba Schizonepetae oil 100 gram, Fructus Forsythiae oil 100 grams, plant volatile oil 200 grams, soybean oil 100 grams, mixed and stir, cross 100 mesh sieves, make medicinal liquid; Get gelatin 200 grams, glycerol 70 grams and water 240 by weight 1: 0.35: 1.2 and restrain the encystation material; Above-mentioned medicinal liquid and capsule material 200 grams are pressed into 1000 of soft capsules on encapsulating machine.
Embodiment 5:
Get Herba Schizonepetae oil 50～500 grams, Fructus Forsythiae oil 50～300 grams and plant volatile oil 50～500 grams and soybean oil 0～850 gram, mixed add to 300～1000 grams and stir, cross 100 mesh sieves, make medicinal liquid, by weight got gelatin in 1: 0.3～0.4: 1.2, G ﹠ W is made the capsule material, and above-mentioned medicinal liquid and capsule material 100 grams～300 grams are pressed into 1000 of soft capsules on encapsulating machine.
Claims (1)
1, a kind of compound schizonepeta fat capsule is characterized in that: in 1000, be made up of Herba Schizonepetae oil 50～500 grams, Fructus Forsythiae oil 50～300 grams, plant volatile oil 50～500 grams, soybean oil 0～850 gram and capsule material.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410050545 CN1284555C (en) | 2004-09-28 | 2004-09-28 | Compound fineleaf schizonepeta oil soft capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410050545 CN1284555C (en) | 2004-09-28 | 2004-09-28 | Compound fineleaf schizonepeta oil soft capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1628784A CN1628784A (en) | 2005-06-22 |
| CN1284555C true CN1284555C (en) | 2006-11-15 |
Family
ID=34846052
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410050545 Expired - Fee Related CN1284555C (en) | 2004-09-28 | 2004-09-28 | Compound fineleaf schizonepeta oil soft capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1284555C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101428125B (en) * | 2008-12-19 | 2011-06-29 | 成都青山利康药业有限公司 | Medicament composition with antiviral efficacy |
-
2004
- 2004-09-28 CN CN 200410050545 patent/CN1284555C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1628784A (en) | 2005-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1562151A (en) | Medicinal formulation for treating upper respiratory track infection and its design method | |
| CN1284555C (en) | Compound fineleaf schizonepeta oil soft capsule | |
| CN101856481A (en) | Externally used ointment for dispersing swelling and dissipating binds | |
| CN101313968A (en) | Pseudo-ginseng dragon's blood preparation | |
| CN102872368B (en) | Chinese medicine acupoint application preparation for purging fire for removing toxin | |
| CN101912473A (en) | Medicinal composition for radically treating haemorrhoids | |
| CN1160097C (en) | Health-care kudingcha tea for calming and lowering blood pressure | |
| CN105168500A (en) | Pharmaceutical composition used for curing infantile dental ulcer and preparation method for pharmaceutical composition | |
| CN1436569A (en) | Medicine for treating children's cold and its prepn process | |
| CN102038780A (en) | External medicine for treating burns and preparation method thereof | |
| CN1278727C (en) | Colonitis enteroclysm | |
| CN1259931C (en) | Soft capsule of forsythia fruit oil | |
| CN1292762C (en) | Medicine composition and its preparation method and use | |
| CN1238012C (en) | Chinese medicine in the form of spray for treating infection of tonsil | |
| CN1326548C (en) | Medicine for treating gonorrhoea | |
| CN105012642A (en) | Preparation method of traditional Chinese medicine composition capable of promoting blood circulation to remove blood stasis, and stopping bleeding and relieving pain | |
| CN105147856A (en) | Traditional Chinese medicine composition used for treating infantile acute laryngitis | |
| CN104547295A (en) | Cold fever abating tea with special effects | |
| CN111617178A (en) | Tooth-strengthening analgesic and preparation method thereof | |
| CN1162178C (en) | Zhixuening capsule and its preparing process | |
| CN104998019A (en) | Traditional Chinese medicine composition for promoting blood circulation for removing blood stasis and reliving bleeding and pain | |
| CN200954248Y (en) | Asthma acupuncture point therapeutic medicine plaster | |
| CN103301150A (en) | Traditional Chinese medicine powder for treating rhinitis | |
| CN1488372A (en) | Chinese medicine formual for treating heptitis | |
| CN111097033A (en) | Application of Rendan in preparing medicine for treating nerve injury |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |